Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9328753Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$180.9K
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#47,538
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing James Richard Gossage as a PI. Multi-PI records show the full award amount for context.
- 5R01FD006840-03R01A Phase II/III randomized, placebo controlled, double blind study to evaluate the effects of up to 24 weeks of low dose pazopanib on HHT related epistaxis and anemia. IND#144808 June 25, 2020$180.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing James Richard Gossage as a PI.
FY2025 award administered by Hht Foundation International, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardHht Foundation International, Inc.
- 2024R01 Grant Holder